date,action,name,rate,target
Jan-02-19,Upgrade,JP Morgan,Underweight to Overweight,$7
Jan-28-19,Upgrade,Buckingham Research,Neutral to Buy,
Mar-15-19,Resumed,Morgan Stanley,Equal-Weight,$6.50
Apr-25-19,Upgrade,Pivotal Research Group,Hold to Buy,$7
Jun-10-19,Upgrade,Credit Suisse,Neutral to Outperform,$7
